I give Bayer/JNJ credit for running a double-blind trial where only one of the arms got warfarin. It must have been hard to convince the IRB’s that it was ethical to conduct sham warfarin-like monitoring in the Xarelto arm.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.